UnitedHealth Group (NYSE:UNH) Issues FY19 Earnings Guidance

Share on StockTwits

UnitedHealth Group (NYSE:UNH) updated its FY19 earnings guidance on Monday. The company provided EPS guidance of approach $15 for the period, compared to the Thomson Reuters consensus EPS estimate of $14.83. The company issued revenue guidance of ~$242 billion, compared to the consensus revenue estimate of $242.73 billion.UnitedHealth Group also updated its FY20 guidance to $16.25-16.55 EPS.

A number of research firms have weighed in on UNH. Credit Suisse Group set a $293.00 price objective on shares of UnitedHealth Group and gave the company a buy rating in a research note on Thursday, August 29th. UBS Group reduced their price objective on shares of UnitedHealth Group from $281.00 to $257.00 and set a neutral rating for the company in a research note on Thursday, October 17th. SunTrust Banks restated a buy rating and set a $335.00 price objective (up from $310.00) on shares of UnitedHealth Group in a research note on Monday, November 18th. Barclays raised their price objective on shares of UnitedHealth Group from $260.00 to $305.00 and gave the company an overweight rating in a research note on Monday. Finally, Jefferies Financial Group lowered shares of UnitedHealth Group from a buy rating to a hold rating and reduced their price objective for the company from $300.00 to $235.00 in a research note on Thursday, October 10th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of Buy and a consensus price target of $289.39.

Shares of NYSE UNH traded down $0.21 during trading on Monday, reaching $279.66. 2,517,060 shares of the company traded hands, compared to its average volume of 4,483,900. The firm has a 50 day simple moving average of $258.05 and a 200-day simple moving average of $245.34. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $265.15 billion, a PE ratio of 21.71, a P/E/G ratio of 1.48 and a beta of 0.64. UnitedHealth Group has a 52-week low of $208.07 and a 52-week high of $287.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.75 by $0.13. The firm had revenue of $60.35 billion for the quarter, compared to the consensus estimate of $59.84 billion. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the firm posted $3.41 EPS. As a group, research analysts predict that UnitedHealth Group will post 14.96 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.54%. The ex-dividend date is Friday, December 6th. UnitedHealth Group’s payout ratio is presently 33.54%.

In other news, CAO Thomas E. Roos sold 1,177 shares of the firm’s stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $255.04, for a total transaction of $300,182.08. Following the sale, the chief accounting officer now owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP D Ellen Wilson sold 7,400 shares of the firm’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $272.77, for a total transaction of $2,018,498.00. In the last ninety days, insiders have sold 38,577 shares of company stock worth $9,398,080. Insiders own 0.82% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: Exchange-Traded Funds (ETFs)

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

OPG Power Ventures Plc. Declares Dividend of GBX 0.60
OPG Power Ventures Plc. Declares Dividend of GBX 0.60
Zoo Digital Group  Stock Price Crosses Below Fifty Day Moving Average of $82.45
Zoo Digital Group Stock Price Crosses Below Fifty Day Moving Average of $82.45
AC Immune  Stock Rating Reaffirmed by HC Wainwright
AC Immune Stock Rating Reaffirmed by HC Wainwright
Invesco Trust for Investment GradeMncpls  to Issue Monthly Dividend of $0.05
Invesco Trust for Investment GradeMncpls to Issue Monthly Dividend of $0.05
Adamis Pharmaceuticals  Share Price Crosses Below 50-Day Moving Average of $0.77
Adamis Pharmaceuticals Share Price Crosses Below 50-Day Moving Average of $0.77
iShares iBoxx $ High Yield Corporate Bond ETF  Share Price Pass Below 50-Day Moving Average of $86.92
iShares iBoxx $ High Yield Corporate Bond ETF Share Price Pass Below 50-Day Moving Average of $86.92


© 2006-2019 Ticker Report